Who is sponsoring NCT07033117?

NCT07033117 is sponsored by Indiana University.

What drugs are being tested in NCT07033117?

Interventions in NCT07033117: Performance Feedback Reports on Referral and Evaluation Closures, Dialysis Facility Awareness Campaign, Patient Contact via Preferred Method, Phone Call to Dialysis Facility During the Patient's Dialysis Session, Phone Call to Provider, Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show, Audit and Tracking of Patient Contact Attempts Prior to Referral Closure.

What condition does NCT07033117 study?

NCT07033117 studies End Stage Renal Disease (ESRD), Kidney Disease.

Is NCT07033117 still recruiting?

NCT07033117 is currently enrolling by invitation. Last updated 30 October 2025.

Last reviewed 2025-10-30 · How we verify

NCT07033117

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RaDIANT Health Systems Intervention

ENROLLING BY INVITATION NA Last updated 30 October 2025

What this trial tests

NA trial testing Performance Feedback Reports on Referral and Evaluation Closures in End Stage Renal Disease (ESRD) in 14,000 participants. Enrolling by invitation.

Timeline

27 October 2025

Primary endpoint
31 July 2026

31 July 2026

Quick facts

Lead sponsor	Indiana University
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	14,000
Start date	27 October 2025
Primary completion	31 July 2026
Estimated completion	31 July 2026
Sites	5 locations across United States

Drugs / interventions tested

Performance Feedback Reports on Referral and Evaluation Closures
Dialysis Facility Awareness Campaign
Patient Contact via Preferred Method
Phone Call to Dialysis Facility During the Patient's Dialysis Session
Phone Call to Provider
Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show
Audit and Tracking of Patient Contact Attempts Prior to Referral Closure

Conditions studied

End Stage Renal Disease (ESRD) — all drugs for End Stage Renal Disease (ESRD) →
Kidney Disease — all drugs for Kidney Disease →

Sponsor

Indiana University

Who can join

Adults 18 to 80, any sex, with End Stage Renal Disease (ESRD) or Kidney Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for End Stage Renal Disease (ESRD)

Currently open trials in the same condition.

NCT07157397 — Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients · NA · recruiting
NCT07291154 — Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy · NA · recruiting
NCT06836206 — The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi · Phase 1, PHASE2 · recruiting
NCT06712251 — Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular A · NA · active not recruiting
NCT06597201 — Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Ma · Phase 4 · recruiting

Other Indiana University trials

Trials by the same sponsor.

NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07033117 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indiana University
Last refreshed: 30 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07033117.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing